الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 170 |  |  |
| | | from | 170 | | |
Abstract
Uterine artery embolization is a recently introduced technique for management of symptomatic uterine fibroids with proposed advantages. UAE is gaining its popularity as a minimally invasive therapeutic alternative to hysterectomy & myomectomy for patients with symptomatic fibroids
The two main surgical approaches are myomectomy (hysteroscopic or abdominal approach) to remove the fibroids or hysterectomy where the uterus is removed: both are associated with complications. Uterine artery embolization (UAE) was originally devised to reduce pelvic bleeding due to postpartum hemorrhage and is now being used for reduction of fibroid bulk size and heavy menstrual bleeding. UAE offers an advantage over hysterectomy with regards to a shorter hospital stay and a quicker return to routine activities.
The advantage of UAE can be summarized in the following:
- No need for general anesthesia.
- Minimal blood loss with no need for transfusion.
- Short recovery period and hospitalization time.
- No post-operative adhesions.
- Emotionally, physically and sexually have advantages over surgery.
Our study included 23 patients with symptomatic uterine fibroids their ages ranged from 28-49 years.
The main presenting symptoms was heavy bleeding, pelvic pain and pressure symptoms.
Out of the study population, 3 (13 %) cases underwent unilateral UAE, while 20 (87 %) underwent bilateral UAE. Regarding the embolizing material used, PVA